A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT06203210. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Open-label Study of Ifinatamab Deruxtecan (I-DXd), a B7-H3 Antibody Drug Conjugate (ADC), Versus Treatment of Physician's Choice (TPC) in Subjects With Relapsed Small Cell Lung Cancer (SCLC) (IDeate-Lung02)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung cancer (SCLC).
Study identification
- NCT ID
- NCT06203210
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 540 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 20, 2024
- Primary completion
- Jan 29, 2028
- Completion
- Nov 30, 2029
- Last update posted
- Aug 5, 2026
2024 – 2029
United States locations
- U.S. sites
- 30
- U.S. states
- 18
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Highlands Oncology Group | Springdale | Arkansas | 72762 | Recruiting |
| Clinical Research Providence Medical Foundation | Fullerton | California | 92835 | Recruiting |
| UCLA Hematology-Oncology | Los Angeles | California | 90095 | Recruiting |
| UCSF Mission Bay Mission Hall | San Francisco | California | 94115 | Recruiting |
| University of Miami Hospital and Clinics Sylvester Comprehensive Cancer Center | Miami | Florida | 33136 | Recruiting |
| AdventHealth Orlando, Cancer Institute | Orlando | Florida | 32804 | Recruiting |
| H. Lee Moffitt Cancer Center and Research Institute, Inc | Tampa | Florida | 33612 | Not yet recruiting |
| Rush MD Anderson Cancer Center | Chicago | Illinois | 60612 | Recruiting |
| Baptist Health Lexington | Lexington | Kentucky | 40503 | Recruiting |
| University of Maryland Greenebaum Comprehensive Cancer Center | Baltimore | Maryland | 21201 | Recruiting |
| John Hopkins School of Medicine | Baltimore | Maryland | 21287 | Recruiting |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02216 | Recruiting |
| Henry Ford Health System | Detroit | Michigan | 48202 | Not yet recruiting |
| Mercy Clinic Oncology and Hematology Sindelar Cancer Center | St Louis | Missouri | 63128 | Recruiting |
| University of Nebraska Medical Center | Omaha | Nebraska | 68198-6811 | Recruiting |
| Dartmouth-Hitchcock Medical Center | Lebanon | New Hampshire | 03766 | Recruiting |
| Astera Cancer Care | East Brunswick | New Jersey | 08816 | Recruiting |
| Hackensack Meridian Health Jsumc | Neptune City | New Jersey | 07753 | Recruiting |
| Clinical Research Alliance, Inc | Lake Success | New York | 11042 | Recruiting |
| Laura and Isaac Perlmutter Cancer Center at NYU Langone Health Long Island | New York | New York | 10016 | Recruiting |
| New York University Cancer Center - Laura and Isaac | New York | New York | 10016 | Recruiting |
| Montefiore Medical Center Prime | The Bronx | New York | 10461 | Not yet recruiting |
| Cleveland Clinic Mercy Hospital | Canton | Ohio | 44708 | Recruiting |
| Oncology/Hematology Care Clinical Trials, Llc | Cincinnati | Ohio | 45236 | Recruiting |
| Providence Portland Medical Center | Portland | Oregon | 97213 | Not yet recruiting |
| THE WEST CLINIC, PLLC dba West Cancer Center | Germantown | Tennessee | 38138 | Recruiting |
| Houston Methodist Cancer Center | Houston | Texas | 77030 | Recruiting |
| University of Texas Md Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
| Texas Oncology, P.A. - Tyler | Tyler | Texas | 75702 | Recruiting |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 199 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06203210, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 5, 2026 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06203210 live on ClinicalTrials.gov.